BioTrinity 2008 Bio-IT Showcase (formerly known as Discovery Informatics Forum)

Companies and other parties interested in presenting should contact OBN at the earliest opportunity to request one of the ten 15 minutes presentation slots.

Bio-IT Showcase will be a unique forum for delegates from R&D companies to meet the solutions providers which are addressing some of the most pressing and problematic issues facing pharmaceutical and biotechnology companies in the drug discovery pipeline.

The BioTrinity Bio-IT showcase features 15 minute presentations by Bio-IT solutions providers to the biotech and pharma industry.
Wednesday, 16th April 2008
13.00 - 16.00	Programme (4 further slots to be allocated)
	13.00 Physiomics plc Adam Hardy, Business Development and Research, Systems Biology for Cancer Drug Development
	13.15 Equinox Pharma Anthony Baxter, Non-executive Chairman Equinox Pharma Computationally-driven drug discovery
	13.30 Amphora Research Systems Simon Coles, CTO & Co-founder, Amphora Research Systems I.T & I.P for Biotechs - The challenges and solutions
	13.45 Thomson Scientific Dr. Colin Williams, Product Manager Searching and analyzing biological data and patented sequences
	14.00 Tessella Support Services plc Jon Tilbury, Director Adaptive Clinical Trials – better efficiency without impairing integrity
	14.15 Cogenics - Marcel de Leeuw Next Generation Sequencing: Information Technology Challenges
	14.30 semgine GmbH (Germany) Dr Thomas Meyer, Sales Manager Life Sciences Semantic based information retrieval in Life Sciences: visual and associative decision support from basic research to clinics
	14.45 Cresset BioMolecular Discovery Ltd Sally Rose PhD, Director of Business Development Cost-effective hit-finding: virtual screening with molecular fields
	15.00 Dotmatics Stephen Gallagher , CEO Are you making the most of your scientific information?

Background

The Bio-IT showcase is an opportunity for life sciences informatics companies to showcase their offerings, bringing together appropriate solutions to an industry which is seeking to reverse falling R&D productivity, despite a growing global annual R&D budget of $88bn and an extending drug development lifecycle currently about 17 years.

As R&D based organisations try to achieve best value from their drug discovery and development operations, it is crucial that Bio-IT solutions providers maintain maximum contact with their corporate customer base.

This showcase was previously called the "Discovery Informatics Forum", under the UK Bioinformatics Forum branding and network which is organised by OBN. In previous years as a stand alone event over 100 delegates took part in the company showcase, networking and partnering elements to this track.

About the Selection Process

An informed decision will be made based upon information supplied by companies, as well as business intelligence which OBN has gathered through research. Companies who are not selected to present are encouraged to participate in the one-to-one partnering elements of the meeting for the purposes of business development.

PROJECT PARTNERS